These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1990570)

  • 1. The case against the indefinite use of cyclosporine.
    Myers BD; Newton L; Oyer P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):41-2. PubMed ID: 1990570
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical problems in cyclosporine dosing with reference to clinical pharmacology: case histories and discussion.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):16-40. PubMed ID: 2662534
    [No Abstract]   [Full Text] [Related]  

  • 3. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrotoxicity of cyclosporine in liver transplantation.
    Iwatsuki S; Esquivel CO; Klintmalm GB; Gordon RD; Shaw BW; Starzl TE
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):191-5. PubMed ID: 3895661
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan.
    Kawaguchi H; Komatsu Y; Hattori M; Nagata M; Ito K; Takahashi K; Teraoka S; Toma H; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1698-700. PubMed ID: 2652556
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
    Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 8. Is cyclosporine administration in twice daily dose advantageous?
    Savoldi S; Sandrini S; Scolari F; Brunori G; Prati E; Camerini C; Scaini P; Cristinelli L; Maiorca R
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1720-2. PubMed ID: 3274414
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.
    Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
    Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
    [No Abstract]   [Full Text] [Related]  

  • 11. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effects of cyclosporine in cardiac transplantation.
    Miller LW; Pennington DG; McBride LR
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):15-20. PubMed ID: 2349734
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity and the role of cyclosporine in living-related donor transplantation.
    Paller MS
    Am J Kidney Dis; 1990 Nov; 16(5):414-6. PubMed ID: 2239930
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
    Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
    [No Abstract]   [Full Text] [Related]  

  • 15. The spectrum of ciclosporin nephrotoxicity.
    Puschett JB; Greenberg A; Holley J; McCauley J
    Am J Nephrol; 1990; 10(4):296-309. PubMed ID: 2240057
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic Epstein-Barr virus reactivation after renal transplantation: immunosuppression with cyclosporine versus azathioprine.
    Hillebrand G; Castro LA; Schleibner S; Land W; Gurland HJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2179-80. PubMed ID: 2856280
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK; Kupin W; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus.
    Boudreaux JP; McHugh L; Canafax DM; Asher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1811-3. PubMed ID: 3079040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.